Francis John Ballard
#121,336
Most Influential Person Now
Francis John Ballard's AcademicInfluence.com Rankings
Francis John Ballardbiology Degrees
Biology
#7379
World Rank
#10293
Historical Rank
Biochemistry
#1017
World Rank
#1130
Historical Rank

Download Badge
Biology
Francis John Ballard's Degrees
- PhD Biochemistry University of California, Berkeley
- Bachelors Chemistry University of California, Berkeley
Why Is Francis John Ballard Influential?
(Suggest an Edit or Addition)Francis John Ballard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phosphoenolpyruvate carboxykinase and pyruvate carboxylase in developing rat liver. (1967) (345)
- Production and utilization of acetate in mammals. (1974) (319)
- The relative significance of acetate and glucose as precursors for lipid synthesis in liver and adipose tissue from ruminants. (1967) (266)
- Lysosomes : their role in protein breakdown (1987) (246)
- Gluconeogenesis and lipogenesis in tissue from ruminant and nonruminant animals. (1969) (197)
- Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. (1992) (183)
- Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. (1988) (180)
- Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. (1967) (177)
- Changes in lipid synthesis in rat liver during development. (1967) (175)
- New opportunities from the isolation and utilization of whey proteins. (1996) (175)
- Glycogen metabolism in embryonic chick and neonatal rat liver. (1963) (170)
- Inhibition of protein degradation in isolated rat hepatocytes. (1977) (162)
- Selective control of the degradation of normal and aberrant proteins in Reuber H35 hepatoma cells. (1976) (159)
- Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase. (1969) (155)
- Changes in the Growth-Promoting Activity of Human Milk during Lactation (1984) (143)
- Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. (1989) (142)
- A possible physiological role for glyceroneogenesis in rat adipose tissue. (1970) (140)
- 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use. (1983) (133)
- The citrate cleavage pathway and lipogenesis in rat adipose tissue: replenishment of oxaloacetate. (1967) (126)
- Citrate, pyruvate, and lactate contaminants of commercial serum albumin. (1968) (122)
- The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding. (1988) (121)
- IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. (1991) (118)
- Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. (1986) (115)
- Purification and properties of rat liver fructokinase. (1967) (110)
- GLUCOSE UTILIZATION IN MAMMALIAN LIVER. (1965) (109)
- CARBOHYDRATE METABOLISM IN LIVER FROM FOETAL AND NEONATAL SHEEP. (1965) (108)
- Chicken insulin-like growth factor-I: amino acid sequence, radioimmunoassay, and plasma levels between strains and during growth. (1990) (103)
- Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum. (1986) (101)
- Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. (1992) (100)
- Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. (1992) (95)
- The regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat kidney cortex. The role of acid-base balance and glucocorticoids. (1975) (95)
- Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. (1990) (93)
- Reduced rates of proteolysis in transformed cells (1977) (93)
- Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver. (1974) (92)
- Synthesis and degradation of phosphoenolpyruvate carboxylase in rat liver and adipose tissue. Changes during a starvation-re-feeding cycle. (1973) (92)
- Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. (1987) (90)
- Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. (1969) (87)
- Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. (1991) (85)
- Effects of carbohydrate availability on lipogenesis in sheep. (1972) (79)
- The effect of ethanol and acetaldehyde on DNA synthesis in growing cells and on fetal development in the rat. (1981) (79)
- Report on the nomenclature of the IGF binding proteins. (1992) (79)
- Extraction from cheese whey by cation-exchange chromatography of factors that stimulate the growth of mammalian cells. (1995) (76)
- Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in the rat. (1975) (75)
- Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion. (1979) (74)
- Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. (1993) (74)
- Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. (1991) (74)
- Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins. (1992) (73)
- Influence of nutrition on hepatic IGF-I mRNA levels and plasma concentrations of IGF-I and IGF-II in meat-type chickens. (1996) (72)
- Purification and properties of galactokinase from pig liver. (1966) (71)
- Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. (1993) (70)
- The appearance of gluconeogenesis at birth in sheep. Activation of the pathway associated with blood oxygenation. (1977) (68)
- Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities. (1988) (68)
- Protein degradation in hepatocyte monolayers. Effects of glucagon, adenosine 3':5'-cyclic monophosphate and insulin. (1980) (67)
- Sheep insulin-like growth factors I and II: sequences, activities and assays. (1989) (67)
- Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion. (1979) (66)
- Inhibition of protein breakdown in cultured cells is a consistent response to growth factors (1980) (66)
- Effects of cyclic adenosine monophosphate, dexamethasone and insulin on phosphoenolpyruvate carboxykinase synthesis in Reuber H-35 hepatoma cells. (1975) (65)
- Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. (1998) (65)
- The initial synthesis of proteins during development. Phosphoenolpyruvate carboxylase in rat liver at birth. (1972) (63)
- Growth factor concentrations and growth-promoting activity in human milk following premature birth. (1985) (62)
- A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. (1989) (62)
- Rapid and reversible inhibition of junctional communication by tumor promoters in a mouse cell line. (1983) (62)
- Transforming growth factor beta in bovine milk: concentration, stability and molecular mass forms. (1996) (61)
- Metabolic Changes in Liver Associated with Spontaneous Ketosis and Starvation in Cows (1968) (60)
- Effects of anabolic agents on protein breakdown in L6 myoblasts. (1983) (59)
- Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. (1991) (59)
- Ketohexokinase, isoenzymes of glucokinase and glycogen synthesis from hexoses in neonatal rat liver. (1964) (57)
- Utilization of oxidizable substrates by the sheep hind limb: effects of starvation and exercise. (1976) (55)
- Identification of vitronectin as a novel insulin-like growth factor-II binding protein. (1999) (54)
- Insulin inhibition of protein degradation in cell monolayers (1980) (54)
- Immunochemical studies with soluble and mitochondrial pyruvate carboxylase activities from rat tissues. (1970) (53)
- Regulation of protein accumulation in cultured cells. (1982) (53)
- Increased degradation rates of protein synthesized in hepatoma cells in the presence of amino acid analogues. (1975) (53)
- The development of gluconeogenesis in rat liver: experiments in vivo. (1969) (52)
- DEVELOPMENTAL CHANGES IN THE PLASMA PROTEIN PATTERN OF THE RAT. (1963) (52)
- Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. (1996) (52)
- The development of gluconeogenesis in rat liver. Controlling factors in the newborn. (1971) (52)
- Treatment with IGF-I peptides improves function of the remnant gut following small bowel resection in rats. (1994) (50)
- Developmental changes in growth hormone, insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in plasma of young growing pigs. (1991) (49)
- Metabolism of glucose, fructose and lactate in vivo in chronically cannulated foetuses and in suckling lambs. (1977) (47)
- Purification, partial sequences and properties of chicken insulin-like growth factors. (1988) (46)
- Alterations in translatable messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) in rat liver cytosol during deinduction. (1978) (45)
- Kinetic studies with liver galactokinase. (1966) (44)
- Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively. (1988) (44)
- Increased rates of myofibrillar protein breakdown in muscle‐wasting diseases (1981) (44)
- Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II. (1989) (44)
- Enzyme inactivation via disulphide-thiol exchange as catalysed by a rat liver membrane protein. (1980) (43)
- Ontogeny and secretory patterns of plasma insulin-like growth factor-I concentrations in meat-type chickens. (1990) (43)
- Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. (1993) (42)
- Evolution of insulin-like growth factor binding proteins. (1993) (42)
- Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells (1995) (42)
- Insulin-like growth factor-I (IGF-I) and IGF-binding proteins both decline in the rat during late pregnancy. (1990) (41)
- Evolution of insulin-like growth factor-I (IGF-I) action: in vitro characterization of vertebrate IGF-I proteins. (1998) (41)
- The regulation of phosphoenolpyruvate carboxykinase in fetal rat liver. (1973) (39)
- The relationship between the insulin content and inhibitory effects of bovine colostrum on protein breakdown in cultured cells (1982) (39)
- Intracellular protein degradation. (1977) (39)
- Infulence of hormones and medium composition on the degradation of phosphoenolpyruvate carboxykinase (GTP) and total protein in Reuber H35 cells. (1976) (39)
- Kinetic studies with cytosol and mitochondrial phosphoenolpyruvate carboxykinases. (1970) (38)
- Stimulation by glucocorticoids of protein degradation in hepatocyte monolayers. (1981) (38)
- Multiple biotin-containing proteins in 3T3-L1 cells. (1986) (36)
- Transport of IGF-I across epithelial cell monolayers. (1999) (36)
- Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor beta do not account for the cell growth activity present in bovine milk. (1997) (36)
- Is dietary epidermal growth factor absorbed by premature human infants? (1989) (36)
- An insulin-like growth factor-binding protein purified from medium conditioned by a human lung fibroblast cell line (He[39]L) has a novel N-terminal sequence. (1990) (36)
- The effect of concentration on glucose phosphorylation and incorporation into glycogen in the livers of foetal and adult rats and sheep. (1964) (36)
- The role of the adrenals in the regulation of phosphoenolpyruvate carboxykinase of rat adipose tissue. (1969) (35)
- Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. (1995) (35)
- Nutritional and Hormonal Effects on Intracellular Protein Catabolism. (2009) (34)
- Plasma clearance of chicken and human insulin-like growth factor-I and their association with circulating binding proteins in chickens. (1990) (34)
- Regulation of phosphoenolpyruvate carboxykinase (GTP) in adipose tissue in vivo by glucocorticoids and insulin. (1976) (33)
- Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. (1995) (33)
- Administration of insulin-like growth factor-I, but not growth hormone, increases maternal weight gain in late pregnancy without affecting fetal or placental growth. (1991) (33)
- Probing the disulfide folding pathway of insulin-like growth factor-I. (1999) (33)
- Distribution and degradation of biotin-containing carboxylases in human cell lines. (1985) (32)
- Metabolic and endocrine interrelationships in normal and diabetic sheep. (1974) (32)
- Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice. (1990) (32)
- Amino acid uptake and output by the sheep hind limb. (1976) (32)
- Adenine nucleotides and the adenylate kinase equilibrium in livers of foetal and newborn rats. (1970) (31)
- Pathway of carbon flow during fatty acid synthesis from lactate and pyruvate in rat adipose tissue. (1971) (31)
- Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1. (1986) (31)
- The development of gluconeogenesis in rat liver. Effects of glucagon and ether. (1970) (31)
- Effects of weak bases on the degradation of endogenous and exogenous proteins by rat yolk sacs. (1980) (30)
- Phosphopyruvate carboxylase induction by L-tryptophan. Effects on synthesis and degradation of the enzyme. (1973) (30)
- Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during human pregnancy. (1991) (30)
- Regulation of gluconeogenesis during exposure of young rats to hypoxic conditions. (1971) (30)
- Identification of fibroblast growth factors in bovine cheese whey (1995) (30)
- Phosphoenolpyruvate synthesis and release by mitochondria from guinea pig liver. (1969) (30)
- Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. (2002) (30)
- Degradation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in vivo and in vitro. (1974) (30)
- Regulation of phosphoenolpyruvate metabolism in mitochondria from guinea pig liver. (1970) (29)
- Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs. (1993) (29)
- The metabolic fate of the products of citrate cleavage. Adenosine triphosphate-citrate lyase and nicotinamide-adenine dinucleotide phosphate-linked malate dehydrogenase in foetal and adult liver from ruminants and non-ruminants. (1968) (29)
- Energy metabolism in free-living, ‘large-eating’ and ‘small-eating’ women: studies using 2H218O (1994) (29)
- Evolution of insulin-like growth factor (IGF) function: production and characterization of recombinant hagfish IGF. (1997) (28)
- The relative stability of liver cytosol enzymes incubated in vitro. (1974) (28)
- Is orally-derived epidermal growth factor beneficial following premature birth or intestinal resection? (1986) (28)
- Chemical and biological characterization of chicken insulin-like growth factor-II. (1990) (28)
- In vivo actions of IGF analogues with poor affinities for IGFBPs: metabolic and growth effects in pigs of different ages and GH responsiveness. (1995) (28)
- Production and characterization of recombinant chicken insulin-like growth factor-I from Escherichia coli. (1992) (27)
- Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. (1994) (27)
- Muscle protein degradation in premature human infants. (1979) (26)
- Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. (1995) (26)
- Measurement of adipose-tissue metabolites in vivo. (1969) (25)
- Characterization of insulin-like growth factor-binding proteins in rat serum, lymph, cerebrospinal and amniotic fluids, and in media conditioned by liver, bone and muscle cells. (1990) (24)
- Appearance of Fructose-1,6-Diphosphatase in Post-Natal Rat Liver (1962) (24)
- Regulation of the breakdown rates of biotin-containing proteins in Swiss 3T3-L1 cells. (1988) (24)
- Differences in energy metabolism between normal weight ‘large-eating’ and ‘small-eating’ women (1992) (24)
- Liver growth in early postpartum rat. (1962) (23)
- Effects of microbial proteinase inhibitors on the degradation of endogenous and internalized proteins by rat yolk sacs. (1981) (23)
- The effect of insulin and glucocorticoids on the synthesis and degradation of phosphoenolpyruvate carboxykinase (GTP) in rat adipose tissue cultured in vitro. (1976) (23)
- A rapid method for the analysis of N tau-methylhistidine in human urine. (1981) (23)
- Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects. (1993) (23)
- Changes in protein synthesis and breakdown rates and responsiveness to growth factors with ageing in human lung fibroblasts (1985) (21)
- Differential changes in the milk concentrations of epidermal growth factor and insulin-like growth factor-I during lactation in the tammar wallaby, Macropus eugenii. (1995) (20)
- IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. (1997) (20)
- IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass. (1991) (20)
- Characterization and cloning of a bovine insulin-like growth factor-binding protein. (1990) (20)
- Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. (1996) (19)
- Inhibition of pyruvate carboxylase degradation and total protein breakdown by lysosomotropic agents in 3T3-L1 cells. (1983) (19)
- Inactivation of phosphoenolypyruvate carboxykinase (GTP) by liver extracts. (1976) (19)
- Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. (1999) (19)
- Modification of animal growth with growth hormone and insulin-like growth factors (1993) (19)
- Factors controlling the concentration of mitochondrial oxaloacetate in liver during spontaneous bovine ketosis. (1968) (18)
- Conjoint IGF-I and Insulin Infusion Shows Diverse Interactive Effects in Diabetic Rats (1996) (17)
- Phosphoenolpyruvate carboxykinase. II. Hormonal controls. (1973) (17)
- Insulin-like growth factor-binding proteins in tissue fluids from the lamb. (1991) (17)
- C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells. (1987) (17)
- The progression of Duchenne muscular dystrophy (1981) (17)
- Growth hormone but not insulin‐like growth factor‐I improves wound strength in pigs (1997) (16)
- Characterization of serum-derived and recombinant rat IGF-I and their use for measuring true concentrations of IGF-I in rat plasma. (1996) (16)
- Synthesis of insulin-like growth factor I using N-methyl pyrrolidinone as the coupling solvent and trifluoromethane sulphonic acid cleavage from the resin. (2009) (15)
- Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction. (1991) (15)
- Creatinine excretion as an index of myofibrillar protein mass in dystrophic mice. (1981) (15)
- Distribution and partial purification of a liver membrane protein capable of inactivating cytosol enzymes. (1980) (15)
- THE SIGNIFICANCE OF MITOCHONDRIAL PHOSPHOENOLPYRUVATE FORMATION IN THE REGULATION OF GLUCONEOGENESIS IN GUINEA PIG LIVER (1972) (15)
- Measurements of myofibrillar protein breakdown in newborn human infants. (1982) (14)
- Inhibition of protein breakdown by epidermal growth factor in IMR90 human fibroblasts and other mammalian cell lines. (1983) (14)
- Effects of insulin-like growth factors on protein metabolism: why are some molecular variants more potent? (1989) (14)
- Factors in ruminant colostrum that influence cell growth and murine IgE antibody responses (1992) (13)
- Effects of insulin-like growth factor-I peptides in rats with acute renal failure. (1994) (13)
- Regulation of protein breakdown by epidermal growth factor in A431 cells. (1985) (13)
- Synthesis of phosphoenolpyruvate carboxykinase (guanosine triphosphate) by isolated liver polyribosomes. (1974) (13)
- Role of mitochondria in metabolism of pyruvate and lactate by rat adipose tissue. (1971) (13)
- Properties of synthetic-gene recombinant human epidermal growth factor: comparison with the natural growth factor from human urine and milk. (1986) (12)
- No major differences in energy metabolism between matched and unmatched groups of ‘large-eating’ and ‘small-eating’ men (1993) (12)
- Effects of fasting and refeeding on the concentrations of glycolytic intermediates and the regulation of lipogenesis in rat adipose tissue in vivo. (1972) (12)
- Pyruvate dehydrogenase activity in rat liver during development. (1974) (11)
- Rapid changes in plasma concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IGF-binding proteins during anaesthesia in young sheep. (1994) (11)
- CHAPTER 3 – Hormonal Control of Protein Degradation in Liver and Isolated Cells (1980) (11)
- Properties of phosphoenolpyruvate carboxykinase (guanosine triphosphate) synthesized in hepatoma cells in the presence of amino acid analogues. (1975) (11)
- Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin‐like growth factor (IGF)‐I (1996) (11)
- Carbohydrate Metabolism and the Regulation of Blood Glucose (1978) (10)
- Plasma half-lives of native and modified insulin-like growth factor-I in lambs. (1988) (10)
- Regulation of intracellular protein degradation by insulin and growth factors. (1981) (10)
- Expression, purification and characterization of secreted recombinant human insulin-like growth factor-I (IGF-I) and the potent variant des(1-3) IGF-I in Chinese hamster ovary cells. (1991) (10)
- Electrophoretic and chromatographic separation of phosphoenolpyruvate carboxykinases. (1971) (9)
- In vitro characterization and in vivo clearance of recombinant barramundi (Lates calcarifer) IGF-I (1999) (9)
- Physiological role and regulation of glyceroneogenesis in rat adipose tissue. (1972) (8)
- Growth hormone-induced changes in myofibrillar protein breakdown in hypopituitary children. (1983) (8)
- Effects of amino acid analogues on protein synthesis and degradation in isolated cells (1978) (8)
- Differences in substrate metabolism between self-perceived 'large-eating' and 'small-eating' women. (1995) (8)
- Insulin-like growth factor I and its variant, des(1-3)IGF-I, improve nitrogen balance and food utilization in rats with renal failure. (1992) (7)
- Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins. (1994) (7)
- Proceedings: Gluconeogenesis in fetal and neonatal lambs. (1974) (7)
- Glyceride-Glycerol Synthesis from Pyruvate (2003) (7)
- The epidermal growth factor-mediated inhibition of growth in A431 cells is accompanied by an atypical stimulation of protein breakdown. (1984) (7)
- The development of gluconeogenic function in rat liver. (1970) (7)
- Degradation of extracellular protein by the isolated perfused rat liver. A biochemical and autoradiographic study. (1979) (6)
- Regulation of protein breakdown in hepatocyte monolayers. (1979) (6)
- Accelerated breakdown of reticulocyte protein formed under conditions of amino acid depletion. (1978) (6)
- The role of pyruvate carboxylase and phosphopyruvate carboxylase (P-enolpyruvate carboxykinase) in adipose tissue. (1970) (6)
- [7] Galactokinase from pig liver (1975) (6)
- Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli. (1995) (6)
- Protein synthesis and breakdown rates associated with the insulin resistance of fibroblasts from patients with leprechaunism. (1985) (6)
- Degradation of native and modified forms of fructose-bisphosphate aldolase microinjected into HeLa cells. (1988) (4)
- Pathways of fructose conversion into glucose in foetal rat liver. (1965) (4)
- ALLOPURINOL INEFFECTIVE IN DUCHENNE MUSCULAR DYSTROPHY (1981) (4)
- Inactivation of Cytosol Enzymes by a Liver Membrane Fraction (1981) (4)
- The concentrations of metabolites of glucose in rat adipose tissue cells in vitro. (1970) (4)
- Degradation of horseradish peroxidase after microinjection into mammalian cells. (1988) (4)
- Attempts to relate enzyme inactivation to degradation in vivo. (1977) (3)
- Proteolysis of N-ethylmaleimide-modified aldolase loaded into erythrocyte ghosts: prevention by inhibitors of calpain. (1989) (3)
- Effects of inhibitors on aldolase breakdown after its microinjection into HeLa cells. (1989) (3)
- Partial isolation and translation in vitro of messenger ribonucleic acid for phosphoenolpyruvate carboxykinase (guanosine triphosphate). (1976) (3)
- Coordinate regulation of protein synthesis and breakdown in cultured cells. (1985) (3)
- Cell culture as a tool for identifying nutritional disease therapies. (1994) (3)
- Effects of insulin on protein synthesis in muscles from normal and dystrophic mice (1983) (2)
- Sequential urinary Nτ‐methylhistidine to creatinine ratios in premature infants (1986) (2)
- Degradation of Enzymes (1980) (2)
- The relationship between insulin binding and the inhibition of protein degradation in normal and transformed cells. (1980) (2)
- Increased Degradation Rates of Canavanine-Containing Proteins in Hepatoma Cells (1977) (2)
- Regulation of protein metabolism and DNA synthesis by fibroblast growth factor in BHK-21 cells. (1988) (2)
- Changes in Protein Synthesis and Degradation Involved in Enzyme Accumulation in Differentiating Liver (1973) (2)
- Degradation of microinjected glycolytic enzymes in L6 myoblasts. (1986) (1)
- Galactokinase from pig liver. (1975) (1)
- The Role of Pyruvate Carboxylase and P-enolpyruvate Carboxykinase in Rat Adipose Tissue (1971) (1)
- The progression of Duchenne muscular dystrophy (1981) (1)
- Structure‐Function Studies on Bombesin and Related Peptides: Biological Effects on Swiss 3T3 Cells and Two‐Dimensional 1H‐NMR Analysis (1988) (1)
- Inactivation of cytosol enzymes by a liver membrane protein. (1979) (1)
- Muscle protein breakdown in premature human infants. (1989) (1)
- The synthesis of lipid from acetate by bovine teat canal epithelium in vitro. A preliminary report. (1968) (1)
- MUSCLE PROTEIN BREAKDOWN IN HUMAN CATABOLIC STATES (1981) (1)
- Ribosomal patterns from fetal and newborn rat liver (1969) (1)
- A Potent Growth Factor Supplement For Cell Culture Purified From Whey (1997) (1)
- Procede de traitement de troubles intestinaux (1991) (0)
- Method for the treatment of intestinal diseases (1991) (0)
- Development of Unique Growth Factors for Serum-Free Cell Culture using Fusion Partner Technology (1997) (0)
- Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. (1999) (0)
- Production of a Novel Recombinant TGFα-Like Fusion Protein for Use in Serum-Free Media (1999) (0)
- IGF analogues: their development and use (1996) (0)
- Structure/function studies on bombesin and related peptides: Their biological effects on swiss 3T3 cells and two-dimensional 1H NMR analyses (1987) (0)
- Book Review:The Insulin-Like Growth Factors: Structure and Biological Functions. Paul N. Schofield (1993) (0)
- Letters to the editor (1982) (0)
- Milk growth factors: concentrations in human milk and effects of premature birth (1985) (0)
- Modified growth factor of milk (1995) (0)
- Insulin-like growth factor ( IGF )-ll binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-11 (2005) (0)
- A rapid, automated method for the determination of 3-methylhistidine in human urine (1982) (0)
- Insulin-like growth factor-I and insulin are synergistic for reversal of catabolism (1996) (0)
- Intellectual property licensing : a case study of dairy wastes : Foods of the Future (1996) (0)
- Restricted nutrition and protein turnover. (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Francis John Ballard?
Francis John Ballard is affiliated with the following schools: